KRAS and anal squamous cell carcinoma: Moreover, cetuximab may be an effective treatment for anal squamous cell carcinoma because EGFR is overexpressed in many cases, while KRAS, NRAS, and BRAF mutations are not observed in most cases [14, 40–42].